Spinal kord stimulasyonunun Retrospektif Analizi: 15 Yıllık Tek Merkez Deneyimi

Yıl 2025, Cilt: 47 Sayı: 6, 923 - 930, 26.09.2025

Ümit Akkemik , Sinan Oğuzhan Ulukaya , Tuba Tanyel Saraçoğlu , Mehmet Sacit Güleç , Ayten Bilir

https://doi.org/10.20515/otd.1718154

Öz

Spinal kord stimülasyonu (SKS), kronik ağrı yönetimi için belirlenmiş bir nöromodülasyon tekniğidir. Bu çalışma, çeşitli kronik ağrı durumlarında SKS tedavisinin sonuçlarını ve komplikasyonlarını değerlendirmektedir. Bu retrospektif, tek merkezli kohort çalışmasında, Ocak 2008 ile Aralık 2023 arasında SKS implantasyonu uygulanan 61 hasta analiz edildi. Başarılı tedavi, Sayısal Derecelendirme Ölçeği (SDÖ) puanlarında >%50 azalma olarak tanımlandı. Hasta memnuniyeti 5 puanlı Likert ölçeği kullanılarak değerlendirildi. İkincil sonuçlar arasında komplikasyonlar, revizyon gereksinimleri ve cihazın uzun ömürlülüğü yer aldı. Başarısız Sırt Cerrahisi Sendromu (BBCS) en yaygın endikasyondu (%73,8), bunu periferik vasküler hastalık (PVH) (%8,2) izledi. Genel tedavi etkinliği hastaların %90,2'sinde elde edildi ve kompleks bölgesel ağrı sendromu (KBAS), PVH, fantom ağrısı, periferik sinir hasarı, spinal tümör ve felçle ilişkili nöropatik ağrı için %100 başarı oranları elde edildi. BBCS hastaları arasında %86,7'si önemli ağrı azalması elde etti. Hasta memnuniyeti yüksekti, %82.0'ı olumlu memnuniyet bildirdi (%67.2 çok memnun, %14.8 kısmen memnun). Vakaların %16.4'ünde SKS revizyonu gerekti, %8.2'sinde tedavi sonlandırıldı ve %18.0'inde implante edilebilir puls jeneratörü değişimi gerekti. Tedavi başarısızlık oranı sadece %3.3'tü. SKS, çeşitli kronik ağrı durumlarında yüksek tedavi etkinliği ve hasta memnuniyeti gösterdi. Düşük tedavi başarısızlık oranlarına sahip olumlu güvenlik profili, uygun hasta seçimi kriterleriyle uygulandığında SKS'yi kapsamlı ağrı yönetimi stratejilerinin önemli bir bileşeni olarak desteklemektedir.

Anahtar Kelimeler

Spinal kord stimulasyonu , Kronik ağrı tedavisi , Nöromodülasyon

Retrospective Analysis of Spinal Cord Stimulation: 15-Year Single-Center Experience

Öz

Spinal cord stimulation (SCS) is an established neuromodulation technique for chronic pain management. This study evaluated outcomes and complications of SCS therapy across various chronic pain conditions. This retrospective, single-center cohort study analyzed 61 patients who received SCS implantation between January 2008 and December 2023. Treatment effectiveness was defined as a >50% reduction in Numeric Rating Scale (NRS) scores. Patient satisfaction was assessed using a 5-point Likert scale. Secondary outcomes included complications, revision requirements, and device longevity. Failed Back Surgery Syndrome (FBSS) was the most common indication (73.8%), followed by peripheral vascular disease (PVD) (8.2%). Overall treatment effectiveness was achieved in 90.2% of patients, with 100% success rates for complex regional pain syndrome (CRPS), PVD, phantom pain, peripheral nerve damage, spinal tumor, and stroke-related neuropathic pain. Among FBSS patients, 86.7% achieved significant pain reduction. Patient satisfaction was high, with 82.0% reporting positive satisfaction (67.2% very satisfied, 14.8% partially satisfied). Revision surgery was required in 16.4% of cases, treatment termination occurred in 8.2%, and implantable pulse generator replacement was necessary in 18.0%. Treatment failure rate was only 3.3%. SCS demonstrated high treatment effectiveness and patient satisfaction across various chronic pain conditions. The favorable safety profile with low treatment failure rates supports SCS as an important component of comprehensive pain management strategies when applied with appropriate patient selection criteria.

Anahtar Kelimeler

Spinal cord stimulation , Chronic pain management , Neuromodulation

Etik Beyan

The study was approved by the EOGÜ-GOKAEK Ethics Committee (Decision no: 144, Date: 29.04.2025) in accordance with the principles of the Declaration of Helsinki.

Kaynakça

• 1. Sdrulla AD, Guan Y, Raja SN. Spinal Cord Stimulation: Clinical Efficacy and Potential Mechanisms. Pain Pract. 2018 Nov;18(8):1048-1067. doi: 10.1111/papr.12692. Epub 2018 Apr 23. PMID: 29526043; PMCID: PMC6391880.
• 2. Kumar K, Taylor RS, Jacques L, Eldabe S, Meglio M, Molet J, Thomson S, O’Callaghan J, Eisenberg E, Milbouw G, Buchser E. Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain. 2007 Nov 1;132(1-2):179-88.
• 3. Mattie R, Lin AB, Bhandal H, Gill B, Tram J, Braun S, Prabakar N, Yin CT, Brar N, Fox A, Saltychev M. Spinal cord stimulation for the treatment of complex regional pain syndrome: A systematic review of randomized controlled trials. Interventional Pain Medicine. 2024 Dec 1;3(4):100527.
• 4. Asimakidou E, Matis GK. Spinal cord stimulation in the treatment of peripheral vascular disease: a systematic review–revival of a promising therapeutic option?. British Journal of Neurosurgery. 2022 Sep 3;36(5):555-63.
• 5. Jaffee S, Verma R, Vaezi M, Kite T, Tomycz N. A scoping review of spinal cord stimulation for phantom limb pain. Interventional Pain Medicine. 2025 Mar 1;4(1):100571.
• 6. Deer TR, Russo M, Grider JS, Sayed D, Lamer TJ, Dickerson DM et al. The neurostimulation appropriateness consensus committee (NACC)®: recommendations for spinal cord stimulation long-term outcome optimization and salvage therapy. Neuromodulation: Technology at the Neural Interface. 2024 Jun 19.
• 7. Eldabe S, Buchser E, Duarte RV. Complications of spinal cord stimulation and peripheral nerve stimulation techniques: a review of the literature. Pain Med. 2016;17(2):325-336.
• 8. Thomson SJ, Kruglov D, Duarte RV. A spinal cord stimulation service review from a single centre using a single manufacturer over a 7.5 year follow-up period. Neuromodulation. 2017;20(6):589-599.
• 9. Brill S, Defrin R, Aryeh IG, Zusman AM, Benyamini Y. Short‐and long‐term effects of conventional spinal cord stimulation on chronic pain and health perceptions: A longitudinal controlled trial. European Journal of Pain. 2022 Oct;26(9):1849-62.
• 10. Martin SC, Baranidharan G, Thomson S, et al. Spinal cord stimulation improves quality of life for patients with chronic pain—data from the UK and Ireland National Neuromodulation Registry. Neuromodulation. 2024;27(8):1406-1418.
• 11. O'Connell NE, Ferraro MC, Gibson W, et al. Implanted spinal neuromodulation interventions for chronic pain in adults. Cochrane Database Syst Rev. 2021;12:CD013756.
• 12. Traeger AC, Gilbert SE, Harris IA, Maher CG. Spinal cord stimulation for low back pain. Cochrane Database Syst Rev. 2023;3:CD014789.
• 13. De Negri P, Paz-Solis JF, Rigoard P, Raoul S, Kallewaard JW, Gulve A, Thomson S, Canós-Verdecho MA, Love-Jones S, Williams A, Rascón-Ramírez FJ. Real-world outcomes of single-stage spinal cord stimulation in chronic pain patients: A multicentre, European case series. Interventional Pain Medicine. 2023 Sep 1;2(3):100263.
• 14. Kurt E, Noordhof RK, van Dongen R, Vissers K, Henssen D, Engels Y. Spinal Cord Stimulation in Failed Back Surgery Syndrome: An Integrative Review of Quantitative and Qualitative Studies. Neuromodulation. 2022;25:657-670.
• 15. Rosenow JM, Stanton-Hicks M, Rezai AR, Henderson JM. Failure modes of spinal cord stimulation hardware. Journal of Neurosurgery: Spine. 2006;5:183-190.
• 16. Rauck RL, Loudermilk E, Thomson SJ, Paz-Solis JF, Bojrab L, Noles J, Vesper J, Atallah J, Roth D, Hegarty J, Prud’Homme M. Long-term safety of spinal cord stimulation systems in a prospective, global registry of patients with chronic pain. Pain management. 2023 Feb 1;13(2):115-27.
• 17. Deer TR, Pope JE, Falowski SM, Pilitsis JG, Hunter CW, Burton AW, Connolly AT, Verrills P. Clinical longevity of 106,462 rechargeable and primary cell spinal cord stimulators: real world study in the medicare population. Neuromodulation: Technology at the Neural Interface. 2023 Jan 1;26(1):131-8.
• 18. Hagedorn JM, Romero J, Ha CT, D’Souza RS. Patient satisfaction with spinal cord stimulation and dorsal root ganglion stimulation for chronic intractable pain: a systematic review and meta-analysis. Neuromodulation: Technology at the Neural Interface. 2022 Oct 1;25(7):947-55.